Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 6.00
+0.15 (2.56%)
Sep 3, 2025, 2:55 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 19.38 million as of September 3, 2025. Its market cap has increased by 1.54% in one year.
Market Cap
19.38M
Enterprise Value
18.24M
Revenue
2.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.00
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 19.38M, a decrease of -70.00%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 19.38M | -45.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | 351.14M | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 183.76B |
| GSK plc | 58.31B |
| Haleon | 32.30B |
| Smith & Nephew | 12.07B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.94B |
| HUTCHMED (China) | 1.87B |
| Oxford Nanopore Technologies | 1.78B |